164 related articles for article (PubMed ID: 24644245)
1. A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro.
Moreno-Carralero MI; Muñoz-Muñoz JA; Cuadrado-Grande N; López-Rodríguez R; José Hernández-Alfaro M; del-Castillo-Rueda A; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
Am J Hematol; 2014 Jul; 89(7):689-94. PubMed ID: 24644245
[TBL] [Abstract][Full Text] [Related]
2. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.
Mayr R; Griffiths WJ; Hermann M; McFarlane I; Halsall DJ; Finkenstedt A; Douds A; Davies SE; Janecke AR; Vogel W; Cox TM; Zoller H
Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368
[TBL] [Abstract][Full Text] [Related]
3. A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin: A recurrent cause of haemochromatosis in China.
Zhang W; Xu A; Li Y; Zhao S; Zhou D; Wu L; Zhang B; Zhao X; Wang Y; Wang X; Duan W; Wang Q; Nan Y; You H; Jia J; Ou X; Huang J;
Liver Int; 2019 Jun; 39(6):1120-1127. PubMed ID: 30500107
[TBL] [Abstract][Full Text] [Related]
4. Genetic and clinical heterogeneity of ferroportin disease.
Cremonesi L; Forni GL; Soriani N; Lamagna M; Fermo I; Daraio F; Galli A; Pietra D; Malcovati L; Ferrari M; Camaschella C; Cazzola M
Br J Haematol; 2005 Dec; 131(5):663-70. PubMed ID: 16351644
[TBL] [Abstract][Full Text] [Related]
5. Two novel mutations in the SLC40A1 and HFE genes implicated in iron overload in a Spanish man.
Del-Castillo-Rueda A; Moreno-Carralero MI; Alvarez-Sala-Walther LA; Cuadrado-Grande N; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
Eur J Haematol; 2011 Mar; 86(3):260-4. PubMed ID: 21175851
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation.
Griffiths WJ; Mayr R; McFarlane I; Hermann M; Halsall DJ; Zoller H; Cox TM
Hepatology; 2010 Mar; 51(3):788-95. PubMed ID: 19937651
[TBL] [Abstract][Full Text] [Related]
7. A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin-associated iron overload diseases.
Létocart E; Le Gac G; Majore S; Ka C; Radio FC; Gourlaouen I; De Bernardo C; Férec C; Grammatico P
Br J Haematol; 2009 Nov; 147(3):379-85. PubMed ID: 19709084
[TBL] [Abstract][Full Text] [Related]
8. Ferroportin diseases: functional studies, a link between genetic and clinical phenotype.
Détivaud L; Island ML; Jouanolle AM; Ropert M; Bardou-Jacquet E; Le Lan C; Mosser A; Leroyer P; Deugnier Y; David V; Brissot P; Loréal O
Hum Mutat; 2013 Nov; 34(11):1529-36. PubMed ID: 23943237
[TBL] [Abstract][Full Text] [Related]
9. Novel mutations of the ferroportin gene (SLC40A1): analysis of 56 consecutive patients with unexplained iron overload.
Pelucchi S; Mariani R; Salvioni A; Bonfadini S; Riva A; Bertola F; Trombini P; Piperno A
Clin Genet; 2008 Feb; 73(2):171-8. PubMed ID: 18177470
[TBL] [Abstract][Full Text] [Related]
10. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
Praschberger R; Schranz M; Griffiths WJ; Baumgartner N; Hermann M; Lomas DJ; Pietrangelo A; Cox TM; Vogel W; Zoller H
Biochim Biophys Acta; 2014 Sep; 1842(9):1406-12. PubMed ID: 24859227
[TBL] [Abstract][Full Text] [Related]
11. Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.
Mayr R; Janecke AR; Schranz M; Griffiths WJ; Vogel W; Pietrangelo A; Zoller H
J Hepatol; 2010 Nov; 53(5):941-9. PubMed ID: 20691492
[TBL] [Abstract][Full Text] [Related]
12. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron.
Koyama C; Wakusawa S; Hayashi H; Ueno T; Suzuki R; Yano M; Saito H; Okazaki T
Intern Med; 2005 Sep; 44(9):990-3. PubMed ID: 16258219
[TBL] [Abstract][Full Text] [Related]
13. Analysis of SLC40A1 gene at the mRNA level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV.
Speletas M; Kioumi A; Loules G; Hytiroglou P; Tsitouridis J; Christakis J; Germenis AE
Blood Cells Mol Dis; 2008; 40(3):353-9. PubMed ID: 17997113
[TBL] [Abstract][Full Text] [Related]
14. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
[TBL] [Abstract][Full Text] [Related]
15. Iron overload in the Asian community.
Lok CY; Merryweather-Clarke AT; Viprakasit V; Chinthammitr Y; Srichairatanakool S; Limwongse C; Oleesky D; Robins AJ; Hudson J; Wai P; Premawardhena A; de Silva HJ; Dassanayake A; McKeown C; Jackson M; Gama R; Khan N; Newman W; Banait G; Chilton A; Wilson-Morkeh I; Weatherall DJ; Robson KJ
Blood; 2009 Jul; 114(1):20-5. PubMed ID: 19342478
[TBL] [Abstract][Full Text] [Related]
16. The role of genetic factors in patients with hepatocellular carcinoma and iron overload - a prospective series of 234 patients.
Funakoshi N; Chaze I; Alary AS; Tachon G; Cunat S; Giansily-Blaizot M; Bismuth M; Larrey D; Pageaux GP; Schved JF; Donnadieu-Rigole H; Blanc P; Aguilar-Martinez P
Liver Int; 2016 May; 36(5):746-54. PubMed ID: 26474245
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological study of Japanese patients with genetic iron overload syndromes.
Hattori A; Miyajima H; Tomosugi N; Tatsumi Y; Hayashi H; Wakusawa S
Pathol Int; 2012 Sep; 62(9):612-8. PubMed ID: 22924847
[TBL] [Abstract][Full Text] [Related]
18. Characterization of three novel pathogenic SLC40A1 mutations and genotype/phenotype correlations in 7 Italian families with type 4 hereditary hemochromatosis.
Majore S; Bonaccorsi di Patti MC; Valiante M; Polticelli F; Cortese A; Di Bartolomeo S; De Bernardo C; De Muro M; Faienza F; Radio FC; Grammatico P; Musci G
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):464-470. PubMed ID: 29154924
[TBL] [Abstract][Full Text] [Related]
19. A novel mutation in ferroportin implicated in iron overload.
Wallace DF; Dixon JL; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN
J Hepatol; 2007 May; 46(5):921-6. PubMed ID: 17383046
[TBL] [Abstract][Full Text] [Related]
20. SLC40A1 c.1402G-->a results in aberrant splicing, ferroportin truncation after glycine 330, and an autosomal dominant hemochromatosis phenotype.
Lee PL; Gelbart T; West C; Barton JC
Acta Haematol; 2007; 118(4):237-41. PubMed ID: 18160816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
